[ad_1]
Reuters
The benefits of the AstraZeneca vaccine outweigh the risks, the European Medicines Agency (EMA) said, but forwarded its final decisions to an expert panel next Thursday.
“We have asked the experts to investigate the link between vaccines and cases of thrombosis. In this context, all issues are evaluated one by one”, it is mentioned in the announcement to which it is added:
“The experts will reach a conclusion on Thursday and make a public announcement immediately after the end of the meeting.”
However, the EMA states that there is no evidence that the vaccine has caused thrombosis, highlighting that the number of registered cases is not higher than that observed in the general population.
He added that while the investigation continues, the agency remains convinced of the benefits of the vaccine, which it says outweighs the risks.
